Literature DB >> 8384065

Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.

M Osako1, S Yonezawa, B Siddiki, J Huang, J J Ho, Y S Kim, E Sato.   

Abstract

BACKGROUND: Pancreatic cancer has a poor prognosis, and early diagnosis of carcinoma and discrimination between malignant and benign conditions are difficult. Many pancreatic cancer-associated antigens, such as CA 19-9, DU-PAN-2, YPan-1, and SPan-1, have been studied. However, expression of Tn, sialosyl-Tn, and T antigens in tissues of different types of pancreatic neoplasms has not been investigated systematically. Moreover, little is known about the distribution of different types of apomucins in the pancreas.
METHODS: The expression of Tn, sialosyl-Tn, and T antigens and DF3 (mammary type apomucin) and intestinal MRP (intestinal type apomucin) was examined immunohistochemically in 47 pancreatic tumors: 36 invasive ductal carcinomas, 5 intraductal papillary tumors, and 6 adenomas.
RESULTS: In normal pancreatic tissues, neither Tn nor sialosyl-Tn antigen was expressed. In contrast, expression of both Tn and sialosyl-Tn antigens was observed in all the invasive ductal carcinomas and intraductal papillary tumors. None of the adenomas expressed both Tn and sialosyl-Tn. DF3 antigen was expressed in all invasive ductal carcinomas but not in intraductal papillary tumors, whereas intestinal MRP was expressed in all the intraductal papillary tumors but not in the invasive ductal carcinomas.
CONCLUSIONS: The results from this study suggest that the expression of the mucin core protein and mucin carbohydrate antigens is correlated with the biologic behavior of pancreatic tumors. In particular, the expression of mammary type mucin core protein and intestinal type mucin core protein showed a striking contrast between invasive ductal carcinomas with a poor prognosis and intraductal papillary tumors with a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384065     DOI: 10.1002/1097-0142(19930401)71:7<2191::aid-cncr2820710705>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  45 in total

1.  DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.

Authors:  Sho Kitamoto; Norishige Yamada; Seiya Yokoyama; Izumi Houjou; Michiyo Higashi; Masamichi Goto; Surinder K Batra; Suguru Yonezawa
Journal:  Glycobiology       Date:  2010-10-06       Impact factor: 4.313

2.  Pre-existing histological type and developmental mechanism of mucinous noncystic carcinoma of pancreas.

Authors:  K Suda; B Nobukawa; S Yamasaki; F Suzuki; H Shimizu; M Takase
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 3.  The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.

Authors:  Huiyuan Tang; Peter Hsueh; Doron Kletter; Marshall Bern; Brian Haab
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 4.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

5.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

6.  Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Michiyo Higashi; Seiya Yokoyama; Takafumi Yamamoto; Yuko Goto; Ikumi Kitazono; Tsubasa Hiraki; Hiroki Taguchi; Shinichi Hashimoto; Yoshihiko Fukukura; Chihaya Koriyama; Yuko Mataki; Kosei Maemura; Hiroyuki Shinchi; Maneesh Jain; Surinder K Batra; Suguru Yonezawa
Journal:  Pancreas       Date:  2015-07       Impact factor: 3.327

Review 7.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

8.  Quantitative assessment of the diagnostic role of MUC1 in pancreatic ductal adenocarcinoma.

Authors:  Siliang Wang; Xiaodong Chen; Meiyue Tang
Journal:  Tumour Biol       Date:  2014-06-11

9.  A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins.

Authors:  Andrew Porter; Tingting Yue; Lee Heeringa; Steven Day; Edward Suh; Brian B Haab
Journal:  Glycobiology       Date:  2009-11-29       Impact factor: 4.313

10.  Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray.

Authors:  Mikiko Takikita; Sean Altekruse; Charles F Lynch; Mark T Goodman; Brenda Y Hernandez; Mark Green; Wendy Cozen; Myles Cockburn; Maria Sibug Saber; Marie Topor; Chris Zeruto; Behnoush Abedi-Ardekani; Marsha E Reichman; Stephen M Hewitt
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.